6 completed, 1 recruiting, 1 terminated. 8 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 8 | Completed 6, Recruiting 1, Terminated 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Lactulose: new trials by email Literature Review of Lactulose trials Research Report on Lactulose
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Lactulose to Improve Gut Health in Cancer Patients Receiving Immunotherapy Lactulose - Cancer | Phase 1 / Phase 2 | Recruiting | University of Chicago | 55 | 2026-12-15 | 2026-06-16 |
| Intravenous BCAA for HE in ACLF (BCAA-HE-ACLF) Branch Chain Amino Acid, Lactulose - Hepatic Encephalopathy, Acute-On-Chronic Liver Failure | Phase 1 | Completed | Post Graduate Institute of Medical Education and Research, Chandigarh | 182 | 2023-01-17 | 2026-11-17 |
| Intravenous Branched Chain Amino Acids for Hepatic Encephalopathy in ACLF Branched chain amino acid, Lactulose - Hepatic Encephalopathy, Acute-On-Chronic Liver Failure | Phase 1 | Completed | Post Graduate Institute of Medical Education and Research, Chandigarh | 70 | 2019-11-01 | 2022-08-16 |
| Investigation of Thermal Injury on Intestinal Permeability in Both Thermal Injury and Healthy Participants Lactulose and Mannitol solution, Sucralose - Burns | Phase 1 | Terminated | GlaxoSmithKline | 18 | 2018-01-29 | 2019-08-19 |
| Performance of 13C Mannitol for in Vivo Measurement of Small Intestinal Permeability 12C mannitol, Indomethacin, 13C mannitol - Impaired Small Intestinal Permeability | Phase 1 | Completed | Mayo Clinic | 25 | 2015-08-01 | 2019-06-04 |
| Metformin's Effect on Glucagon-induced Glucose Production and Protein Metabolism. Metformin, Placebo - Insulin Resistance, Prediabetic State | Phase 1 | Completed | Mayo Clinic | 12 | 2013-10-01 | 2017-09-01 |
| Kristalose as Bowel Evacuant Prior to Colonoscopy Kristalose - Bowel Evacuant Prior to Colonoscopy | Phase 1 | Completed | Benaroya Research Institute | 20 | 2010-12-01 | 2011-10-06 |
| Safety Study of Intravenous 6β-Naltrexol (AIKO-150) in Opioid-Dependent Subjects 6β-Naltrexol escalating doses from 0.05-0.5 mg IV - Opiate Addiction | Phase 1 | Completed | California Pacific Medical Center Research Institute | 8 | 2009-03-01 | 2009-09-16 |
Acute-On-Chronic Liver Failure (2) · Hepatic Encephalopathy (2) · Brain Edema (1) · Burns (1) · Insulin Resistance (1) · Neoplasms (1) · Opioid-Related Disorders (1) · Prediabetic State (1)
Mayo Clinic (2) · Post Graduate Institute of Medical Education and Research, Chandigarh (2) · Benaroya Research Institute (1) · California Pacific Medical Center Research Institute (1) · GlaxoSmithKline (1) · University of Chicago (1)
United States (5) · India (2) · United Kingdom (1)
Daniel Olson (1) · John E Mendelson, MD (1) · K Nair, MD, PhD (1) · Madhumita Premkumar, MD, DM (1) · Madhusudan Grover, MBBS (1)
PMID 25715177, PMID 30568347, PMID 37975059, PMID 6749458, PMID 818729